Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) just unveiled an announcement.
Predict S.p.A. reported 2025 revenues of €7.60 million, up 14.6% year on year, driven by solid growth in its core Imaging and People Support units and a near‑190% surge in Digital Healthcare sales, particularly from Optip and Aphel installations at major Italian public entities. Despite higher personnel, R&D and service costs compressing the EBITDA margin to 10.3% and limiting net profit to €0.17 million, the company remains cash‑positive with an adjusted net financial position of €2.04 million and is prioritizing investment-led expansion in higher value-added segments to reinforce its competitive positioning and support future profitability, alongside the approval of its 2025 sustainability report.
The performance highlights a deliberate trade-off between short-term margins and long-term growth, as Predict strengthens its workforce and innovation pipeline to scale newer businesses like Digital Healthcare while consolidating traditional med-tech lines. This strategy, underpinned by continued financial solidity, suggests potential benefits for healthcare customers seeking advanced diagnostic solutions and signals to investors a focus on sustainable value creation through balanced growth and disciplined capital structure management.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A. is an Italian innovative SME in the med-tech sector, focused on in vivo diagnostics through the distribution of ultrasound and radiological equipment and the development of breath analysis technologies and digital healthcare solutions. Its business is structured around four strategic units – Imaging, People Support, Mistral and Digital Healthcare – serving both private customers and public healthcare institutions in Italy.
Average Trading Volume: 27,197
Technical Sentiment Signal: Buy
Current Market Cap: €6.86M
See more data about PRE stock on TipRanks’ Stock Analysis page.